BRISTOL-MYERS SQUIBB COMPANY Increase (Decrease) in Inventories
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Increase (Decrease) in Inventories of $22.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for the quarter ending 2026-06-30 was $36.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for the quarter ending 2026-03-31 was -$14.00M, a 108.28% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for the quarter ending 2025-12-31 was -$71.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for the quarter ending 2025-09-30 was $90.00M, a 58.72% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for fiscal 2025 was $184.00M, a 62.14% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for fiscal 2024 was $486.00M, a 35.29% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for fiscal 2023 was $751.00M, a 988.41% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in inventories for fiscal 2022 was $69.00M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $22.00M 10-Q · filed 2026-07-30 | -$49.00M derived: sum of 3 quarters · filed 2026-07-30 | $41.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$14.00M 10-Q · filed 2026-04-30 | -$85.00M derived: sum of 2 quarters · filed 2026-04-30 | $5.00M derived: sum of 3 quarters · filed 2026-04-30 | $1.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $19.00M derived: sum of 2 quarters · filed 2026-02-11 | $15.00M derived: sum of 3 quarters · filed 2026-07-30 | $184.00M 10-K · filed 2026-02-11 | ||
| 2025-09-30 | $90.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $86.00M derived: sum of 2 quarters · filed 2026-07-30 | $255.00M 10-Q · filed 2025-10-30 | $80.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $165.00M 10-Q · filed 2026-07-30 | -$10.00M derived: sum of 3 quarters · filed 2026-07-30 | $208.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $169.00M 10-Q · filed 2026-04-30 | -$6.00M derived: sum of 2 quarters · filed 2026-04-30 | $212.00M derived: sum of 3 quarters · filed 2026-04-30 | $437.00M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | -$175.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $43.00M derived: sum of 2 quarters · filed 2026-02-11 | $268.00M derived: sum of 3 quarters · filed 2026-02-11 | $486.00M 10-K · filed 2026-02-11 | ||
| 2024-09-30 | $218.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $443.00M derived: sum of 2 quarters · filed 2025-10-30 | $661.00M 10-Q · filed 2025-10-30 | $858.00M derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-06-30 | $225.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $443.00M 10-Q · filed 2025-07-31 | $640.00M derived: sum of 3 quarters · filed 2026-02-11 | $896.00M derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-03-31 | $218.00M 10-Q · filed 2025-04-24 | $415.00M derived: sum of 2 quarters · filed 2026-02-11 | $671.00M derived: sum of 3 quarters · filed 2026-02-11 | $687.00M derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2023-12-31 | $197.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $453.00M derived: sum of 2 quarters · filed 2026-02-11 | $469.00M derived: sum of 3 quarters · filed 2026-02-11 | $751.00M 10-K · filed 2026-02-11 | ||
| 2023-09-30 | $256.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $272.00M derived: sum of 2 quarters · filed 2024-10-31 | $554.00M 10-Q · filed 2024-10-31 | $595.00M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-06-30 | $16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $298.00M 10-Q · filed 2024-07-26 | $339.00M derived: sum of 3 quarters · filed 2025-02-12 | $355.00M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-03-31 | $282.00M 10-Q · filed 2024-04-25 | $323.00M derived: sum of 2 quarters · filed 2025-02-12 | $339.00M derived: sum of 3 quarters · filed 2025-02-12 | $352.00M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2022-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $57.00M derived: sum of 2 quarters · filed 2025-02-12 | $70.00M derived: sum of 3 quarters · filed 2025-02-12 | $69.00M 10-K · filed 2025-02-12 | ||
| 2022-09-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $29.00M derived: sum of 2 quarters · filed 2023-10-26 | $28.00M 10-Q · filed 2023-10-26 | $156.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $12.00M 10-Q · filed 2023-07-27 | $140.00M derived: sum of 3 quarters · filed 2024-02-13 | $110.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | -$1.00M 10-Q · filed 2023-04-27 | $127.00M derived: sum of 2 quarters · filed 2024-02-13 | $97.00M derived: sum of 3 quarters · filed 2024-02-13 | $92.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $128.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $98.00M derived: sum of 2 quarters · filed 2024-02-13 | $93.00M derived: sum of 3 quarters · filed 2024-02-13 | -$13.00M 10-K · filed 2024-02-13 | ||
| 2021-09-30 | -$30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | -$35.00M derived: sum of 2 quarters · filed 2022-10-26 | -$141.00M 10-Q · filed 2022-10-26 | -$242.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$111.00M 10-Q · filed 2022-07-27 | -$212.00M derived: sum of 3 quarters · filed 2023-02-14 | -$693.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | -$106.00M 10-Q · filed 2022-04-29 | -$207.00M derived: sum of 2 quarters · filed 2023-02-14 | -$688.00M derived: sum of 3 quarters · filed 2023-02-14 | -$1.33B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | -$101.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$582.00M derived: sum of 2 quarters · filed 2023-02-14 | -$1.22B derived: sum of 3 quarters · filed 2023-02-14 | -$2.67B 10-K · filed 2023-02-14 | ||
| 2020-09-30 | -$481.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$1.12B derived: sum of 2 quarters · filed 2021-10-27 | -$2.57B 10-Q · filed 2021-10-27 | -$3.04B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-06-30 | -$642.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$2.09B 10-Q · filed 2021-07-28 | -$2.56B derived: sum of 3 quarters · filed 2022-02-09 | -$2.52B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-03-31 | -$1.45B 10-Q · filed 2021-04-29 | -$1.92B derived: sum of 2 quarters · filed 2022-02-09 | -$1.88B derived: sum of 3 quarters · filed 2022-02-09 | -$1.88B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2019-12-31 | -$470.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$435.00M derived: sum of 2 quarters · filed 2022-02-09 | -$428.00M derived: sum of 3 quarters · filed 2022-02-09 | -$463.00M 10-K · filed 2022-02-09 | ||
| 2019-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $42.00M derived: sum of 2 quarters · filed 2020-11-05 | $7.00M 10-Q · filed 2020-11-05 | $71.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$28.00M 10-Q · filed 2020-08-06 | $36.00M derived: sum of 3 quarters · filed 2021-02-10 | $66.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-03-31 | -$35.00M 10-Q · filed 2020-05-07 | $29.00M derived: sum of 2 quarters · filed 2021-02-10 | $59.00M derived: sum of 3 quarters · filed 2021-02-10 | $177.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2018-12-31 | $64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $94.00M derived: sum of 2 quarters · filed 2021-02-10 | $212.00M derived: sum of 3 quarters · filed 2021-02-10 | $216.00M 10-K · filed 2021-02-10 | ||
| 2018-09-30 | $30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $148.00M derived: sum of 2 quarters · filed 2019-10-31 | $152.00M 10-Q · filed 2019-10-31 | $188.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-06-30 | $118.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $122.00M 10-Q · filed 2019-07-25 | $158.00M derived: sum of 3 quarters · filed 2020-02-24 | $93.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $4.00M 10-Q · filed 2019-04-25 | $40.00M derived: sum of 2 quarters · filed 2020-02-24 | -$25.00M derived: sum of 3 quarters · filed 2020-02-24 | -$38.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2017-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$29.00M derived: sum of 2 quarters · filed 2020-02-24 | -$42.00M derived: sum of 3 quarters · filed 2020-02-24 | $29.00M 10-K · filed 2020-02-24 | ||
| 2017-09-30 | -$65.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$78.00M derived: sum of 2 quarters · filed 2018-10-25 | -$7.00M 10-Q · filed 2018-10-25 | $38.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-06-30 | -$13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $58.00M 10-Q · filed 2018-07-26 | $103.00M derived: sum of 3 quarters · filed 2019-02-25 | $99.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-03-31 | $71.00M 10-Q · filed 2018-04-26 | $116.00M derived: sum of 2 quarters · filed 2019-02-25 | $112.00M derived: sum of 3 quarters · filed 2019-02-25 | $179.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2016-12-31 | $45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $41.00M derived: sum of 2 quarters · filed 2019-02-25 | $108.00M derived: sum of 3 quarters · filed 2019-02-25 | $152.00M 10-K · filed 2019-02-25 | ||
| 2016-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $63.00M derived: sum of 2 quarters · filed 2017-10-26 | $107.00M 10-Q · filed 2017-10-26 | $241.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-30 | $67.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $111.00M 10-Q · filed 2017-07-27 | $245.00M derived: sum of 3 quarters · filed 2018-02-13 | $176.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-31 | $44.00M 10-Q · filed 2017-04-27 | $178.00M derived: sum of 2 quarters · filed 2018-02-13 | $109.00M derived: sum of 3 quarters · filed 2018-02-13 | -$2.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-31 | $134.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $65.00M derived: sum of 2 quarters · filed 2018-02-13 | -$46.00M derived: sum of 3 quarters · filed 2018-02-13 | -$97.00M 10-K · filed 2018-02-13 | ||
| 2015-09-30 | -$69.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | -$180.00M derived: sum of 2 quarters · filed 2016-10-27 | -$231.00M 10-Q · filed 2016-10-27 | -$139.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-06-30 | -$111.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$162.00M 10-Q · filed 2016-07-28 | -$70.00M derived: sum of 3 quarters · filed 2017-02-21 | -$65.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-03-31 | -$51.00M 10-Q · filed 2016-04-28 | $41.00M derived: sum of 2 quarters · filed 2017-02-21 | $46.00M derived: sum of 3 quarters · filed 2017-02-21 | $59.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2014-12-31 | $92.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $97.00M derived: sum of 2 quarters · filed 2017-02-21 | $110.00M derived: sum of 3 quarters · filed 2017-02-21 | $254.00M 10-K · filed 2017-02-21 | ||
| 2014-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $18.00M derived: sum of 2 quarters · filed 2015-10-27 | $162.00M 10-Q · filed 2015-10-27 | $199.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $157.00M 10-Q · filed 2015-07-23 | $194.00M derived: sum of 3 quarters · filed 2016-02-12 | $29.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-31 | $144.00M 10-Q · filed 2015-04-28 | $181.00M derived: sum of 2 quarters · filed 2016-02-12 | $16.00M derived: sum of 3 quarters · filed 2016-02-12 | $26.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$128.00M derived: sum of 2 quarters · filed 2016-02-12 | -$118.00M derived: sum of 3 quarters · filed 2016-02-12 | $45.00M 10-K · filed 2016-02-12 | ||
| 2013-09-30 | -$165.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | -$155.00M derived: sum of 2 quarters · filed 2014-10-24 | $8.00M 10-Q · filed 2014-10-24 | -$24.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $173.00M 10-Q · filed 2014-07-24 | $141.00M derived: sum of 3 quarters · filed 2015-02-13 | $106.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-03-31 | $163.00M 10-Q · filed 2014-04-29 | $131.00M derived: sum of 2 quarters · filed 2015-02-13 | $96.00M derived: sum of 3 quarters · filed 2015-02-13 | $198.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2012-12-31 | -$32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$67.00M derived: sum of 2 quarters · filed 2015-02-13 | $35.00M derived: sum of 3 quarters · filed 2015-02-13 | $103.00M 10-K · filed 2015-02-13 | ||
| 2012-09-30 | -$35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $67.00M derived: sum of 2 quarters · filed 2013-10-23 | $135.00M 10-Q · filed 2013-10-23 | $178.00M derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2012-06-30 | $102.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $170.00M 10-Q · filed 2013-07-25 | $213.00M derived: sum of 3 quarters · filed 2014-02-14 | $117.00M derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2012-03-31 | $68.00M 10-Q · filed 2013-04-25 | $111.00M derived: sum of 2 quarters · filed 2014-02-14 | $15.00M derived: sum of 3 quarters · filed 2014-02-14 | $177.00M derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2011-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$53.00M derived: sum of 2 quarters · filed 2014-02-14 | $109.00M derived: sum of 3 quarters · filed 2014-02-14 | $193.00M 10-K · filed 2014-02-14 | ||
| 2011-09-30 | -$96.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $66.00M derived: sum of 2 quarters · filed 2012-10-24 | $150.00M 10-Q · filed 2012-10-24 | -$43.00M derived: sum of 4 quarters · filed 2013-02-15 | ||
| 2011-06-30 | $162.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $246.00M 10-Q · filed 2012-07-25 | $53.00M derived: sum of 3 quarters · filed 2013-02-15 | $102.00M derived: sum of 4 quarters · filed 2013-02-15 | ||
| 2011-03-31 | $84.00M 10-Q · filed 2012-04-26 | -$109.00M derived: sum of 2 quarters · filed 2013-02-15 | -$60.00M derived: sum of 3 quarters · filed 2013-02-15 | -$47.00M derived: sum of 4 quarters · filed 2013-02-15 | ||
| 2010-12-31 | -$193.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$144.00M derived: sum of 2 quarters · filed 2013-02-15 | -$131.00M derived: sum of 3 quarters · filed 2013-02-15 | -$156.00M 10-K · filed 2013-02-15 | ||
| 2010-09-30 | $49.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $62.00M derived: sum of 2 quarters · filed 2011-10-27 | $37.00M 10-Q · filed 2011-10-27 | -$37.00M 10-Q · filed 2010-10-26 | -$46.00M derived: sum of 4 quarters · filed 2012-02-17 | |
| 2010-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$12.00M 10-Q · filed 2011-07-28 | $12.00M 10-Q · filed 2010-07-22 | -$95.00M derived: sum of 3 quarters · filed 2012-02-17 | -$84.00M derived: sum of 4 quarters · filed 2012-02-17 | |
| 2010-03-31 | -$25.00M 10-Q · filed 2011-04-28 | -$108.00M derived: sum of 2 quarters · filed 2012-02-17 | -$97.00M derived: sum of 3 quarters · filed 2012-02-17 | -$125.00M derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2009-12-31 | -$83.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | -$72.00M derived: sum of 2 quarters · filed 2012-02-17 | -$100.00M derived: sum of 3 quarters · filed 2012-02-17 | -$82.00M 10-K · filed 2012-02-17 | ||
| 2009-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | -$17.00M derived: sum of 2 quarters · filed 2010-10-26 | $1.00M 10-Q · filed 2010-10-26 | -$1.00M 10-Q · filed 2009-10-22 | -$204.00M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | -$28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | -$10.00M 10-Q · filed 2010-07-22 | $10.00M 10-Q · filed 2009-07-23 | -$215.00M derived: sum of 3 quarters · filed 2011-02-18 | -$218.00M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $18.00M 10-Q · filed 2010-04-29 | -$187.00M derived: sum of 2 quarters · filed 2011-02-18 | -$190.00M derived: sum of 3 quarters · filed 2011-02-18 | |||
| 2008-12-31 | -$205.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | -$208.00M derived: sum of 2 quarters · filed 2011-02-18 | -$130.00M 10-K · filed 2011-02-18 | |||
| 2008-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $75.00M 10-Q · filed 2009-10-22 | ||||
| 2008-06-30 | $78.00M 10-Q · filed 2009-07-23 | |||||
| 2007-12-31 | $54.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |